all report title image
  • Published In : Apr 2024
  • Code : CMI5261
  • Pages : 174
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

The U.S. nasal spray market is estimated to be valued at USD 10.42 Bn in 2024, and is expected to exhibit a CAGR of 6.9% during the forecast period (2024-2031). The U.S. nasal spray market has been witnessing steady growth over the past few years due to rising prevalence of common cold, sinusitis and allergies. Nasal sprays offer instant relief from nasal congestion symptoms, and are preferred over other medications due to their convenience of use. Rapid urbanization and changing lifestyle has led to rising levels of stress, which increases susceptibility to infections and allergies. This has boosted the sales of nasal sprays. However, potential side effects with prolonged use and availability of alternative treatment options are expected to hamper the market growth.

Market Dynamics:

The U.S. nasal spray market growth is driven by increasing prevalence of respiratory infections, allergies and sinusitis. Growing pollution levels in both indoor and outdoor environments has contributed to rising incidence of these conditions. According to Asthma and Allergy Foundation of America, in 2020, more than 50 million Americans suffer from allergies each year. High stress levels associated with fast-paced lifestyle has further increased the problem. Availability of inexpensive generic drugs is another factor hampering the market growth. However, ongoing R&D towards development of advanced formulations with minimal side effects can create new opportunities for existing market players.

Key Features of the Study:

  • This report provides an in-depth analysis of the U.S. nasal spray market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.S. nasal spray market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study Sanofi, GSK plc., Merck & Co., Inc., Novartis AG, Pfizer Inc., AstraZeneca, NeilMed Pharmaceuticals Inc., Neurelis, Inc., Johnson & Johnson Services, Inc., Bayer AG, GLENMARK PHARMACEUTICALS LTD., Bausch Health Companies Inc., Viatris Inc., The Procter & Gamble Company, Cipla, EMERGENT, Hikma Pharmaceuticals PLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The U.S. nasal spray market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. nasal spray market

Detailed Segmentation-

  • By Product Type:
    • Steroid Sprays
    • Antihistamine Sprays
    • Decongestant Sprays
    • Others
  • By Type:
    • Prescription
    • Over-the-Counter
  • By Indication:
    • Allergic Rhinitis
    • Nasal Allergies
    • Nasal Congestion
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Company Profiles:
    • Sanofi
    • GSK plc.
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • AstraZeneca 
    • NeilMed Pharmaceuticals Inc.
    • Neurelis, Inc.
    • Johnson & Johnson Services, Inc.
    • Bayer AG
    • GLENMARK PHARMACEUTICALS LTD.
    • Bausch Health Companies Inc. 
    • Viatris Inc.
    • The Procter & Gamble Company 
    • Cipla
    • EMERGENT 
    • Hikma Pharmaceuticals PLC

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Type
      • Market Snapshot, By Indication
      • Market Snapshot, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Product Launches/Approvals
    • Recent Developments
    • Regulatory Scenario
    • Technological Advancements
    • Manufacturer Revenue
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. U.S. Nasal Spray Market - Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 impact on the market
  5. U.S. Nasal Spray Market, By Product Type, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Steroid Sprays
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Antihistamine Sprays
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Decongestant Sprays
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  6. U.S. Nasal Spray Market, By Type, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Prescription
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Over-the-Counter
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  7. U.S. Nasal Spray Market, By Indication, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Allergic Rhinitis
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Nasal Allergies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Nasal Congestion
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  8. U.S. Nasal Spray Market, By Distribution Channel, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  9. Competitive Landscape
    • Company Profiles
      • Sanofi*
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • GSK plc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novartis AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Pfizer Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • AstraZeneca 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • NeilMed Pharmaceuticals Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Neurelis, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Johnson & Johnson Services, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bayer AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • GLENMARK PHARMACEUTICALS LTD.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bausch Health Companies Inc. 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Viatris Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • The Procter & Gamble Company 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Cipla
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • EMERGENT 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Hikma Pharmaceuticals PLC
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  10. Analyst Recommendations
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 33 market data tables and 25 figures on “Nasal Spray Market” -U.S. forecast to 2031

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo